Christopher R. Concannon - Apr 3, 2023 Form 4 Insider Report for MARKETAXESS HOLDINGS INC (MKTX)

Signature
/s/ Jason Edelstein, as Attorney-in-Fact for Christopher R. Concannon
Stock symbol
MKTX
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2023, 04:15 PM
Previous filing
Feb 17, 2023
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MKTX Common Stock, par value $0.003 per share Award $0 +2.73K +6.79% $0.00 42.9K Apr 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MKTX Performance Stock Units Award $0 +5.04K $0.00 5.04K Apr 3, 2023 Common Stock 5.04K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units pursuant to the Company's 2020 Equity Incentive Plan (the "Plan"). Subject to the terms of the Plan and the Restricted Stock Unit Agreement, the restricted stock units will vest in three installments of 25% on April 3, 2026, 25% on April 3, 2027 and 50% on April 3, 2028.
F2 Each performance stock unit ("PSU") granted pursuant to the Plan represents a contingent right to receive one share of the Company's common stock. 1,260 PSUs shall have a three-year performance period; 1,260 PSUs shall have a four-year performance period; and 2,519 PSUs shall have a five-year performance period. Subject to the terms of the Plan and the Performance Stock Unit Agreement, the PSUs will vest and shares of common stock shall be awarded for each performance period based upon achievement, as determined by the Company's Compensation Committee, of a compound annual growth rate performance metric, calculated using (i) a starting stock price equal to the average closing stock price of each trading day during the thirty (30) calendar days immediately preceding the Grant Date and (ii) an ending stock price equal to the average closing stock price of each trading day during the ninety (90) calendar days ending on the final day of the applicable Performance Period.